Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features
2017 · Gastroenterology · 1,017 citations
https://doi.org/10.1053/j.gastro.2017.06.007
N
Nicholas K. Akers
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
55
Papers
2.6K
Citations
14
h-index
16
i10-index
Nicholas K. Akers is an academic researcher from Adaptive Biotechnologies (United States). The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Hepatocellular Carcinoma Treatment and Prognosis & vaccines and immunoinformatics approaches. The author has an h-index of 14, co-authored 47 publications.
ORCID: 0000-0003-2161-2869Papers by this author
worksAnalytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myeloma
2020 · BMC Cancer · 127 citations
https://doi.org/10.1186/s12885-020-07077-9
Coding Variants at Hexa-allelic Amino Acid 13 of HLA-DRB1 Explain Independent SNP Associations with Follicular Lymphoma Risk
2013 · The American Journal of Human Genetics · 26 citations
https://doi.org/10.1016/j.ajhg.2013.05.020
Tumor fitness, immune exhaustion and clinical outcomes: impact of immune checkpoint inhibitors
2020 · Scientific Reports · 8 citations
https://doi.org/10.1038/s41598-020-61992-2
Correction to: Integrative analysis of loss-of-function variants in clinical and genomic data reveals novel genes associated with cardiovascular traits
2019 · BMC Medical Genomics · 1 citations
https://doi.org/10.1186/s12920-019-0573-9
Additional file 2: of Integrative analysis of loss-of-function variants in clinical and genomic data reveals novel genes associated with cardiovascular traits
2019 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.9109301
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat